PHR
Price
$12.81Alerts
Change
-$0.32 (-2.44%)
Updated
Nov 11, 04:59 PM (EDT)
Capitalization
783.34M
21 days until earnings call
Intraday BUY SELL Signals
VEEV
Price
$304.77Alerts
Change
-$0.78 (-0.26%)
Updated
Nov 11, 04:59 PM (EDT)
Capitalization
49.18B
8 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PHR vs VEEV

PHR vs VEEV Comparison Chart in %
View a ticker or compare two or three
VS
PHR vs. VEEV commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHR is a StrongBuy and VEEV is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for PHR with price predictions
Nov 10, 2026

PHR in upward trend: 10-day moving average broke above 50-day moving average on October 21, 2026

The 10-day moving average for PHR crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on PHR as a result. In 68 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

PHR moved above its 50-day moving average on October 19, 2026 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for PHR moved above the 200-day moving average on October 27, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +4.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where PHR advanced for three days, in 217 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

The Aroon Indicator entered an Uptrend today. In 107 of 132 cases where PHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.

Bearish Trend Analysis

The 10-day RSI Indicator for PHR moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 21 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 78%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 52 of 62 cases where PHR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 84%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

PHR broke above its upper Bollinger Band on October 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. PHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.107) is normal, around the industry mean (4.477). PHR has a moderately high P/E Ratio (70.111) as compared to the industry average of (13.414). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.270) is also within normal values, averaging (6.065).

The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

A.I.Advisor
a Summary for VEEV with price predictions
Nov 10, 2026

VEEV sees MACD Histogram crosses below signal line

VEEV saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 28, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 51 instances where the indicator turned negative. In 34 of the 51 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 67%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for VEEV moved out of overbought territory on October 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 23 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 66%.

The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VEEV as a result. In 50 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VEEV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 54 cases where VEEV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.

Following a +0.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where VEEV advanced for three days, in 179 of 275 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.

VEEV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 134 of 210 cases where VEEV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. VEEV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 71 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.617) is normal, around the industry mean (4.477). P/E Ratio (48.989) is within average values for comparable stocks, (13.414). Projected Growth (PEG Ratio) (1.248) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (12.739) is also within normal values, averaging (6.065).

The Tickeron Profit vs. Risk Rating rating for this company is 96 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VEEV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

FUNDAMENTALS RATINGS
PHR vs VEEV: Fundamental Ratings
PHR
VEEV
OUTLOOK RATING
1..100
8583
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
10096
SMR RATING
1..100
8758
PRICE GROWTH RATING
1..100
4237
P/E GROWTH RATING
1..100
9571
SEASONALITY SCORE
1..100
4942

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PHR's Valuation (88) in the null industry is in the same range as VEEV (88) in the Packaged Software industry. This means that PHR’s stock grew similarly to VEEV’s over the last 12 months.

VEEV's Profit vs Risk Rating (96) in the Packaged Software industry is in the same range as PHR (100) in the null industry. This means that VEEV’s stock grew similarly to PHR’s over the last 12 months.

VEEV's SMR Rating (58) in the Packaged Software industry is in the same range as PHR (87) in the null industry. This means that VEEV’s stock grew similarly to PHR’s over the last 12 months.

VEEV's Price Growth Rating (37) in the Packaged Software industry is in the same range as PHR (42) in the null industry. This means that VEEV’s stock grew similarly to PHR’s over the last 12 months.

VEEV's P/E Growth Rating (71) in the Packaged Software industry is in the same range as PHR (95) in the null industry. This means that VEEV’s stock grew similarly to PHR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PHRVEEV
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
66%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
64%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 20 days ago
65%
Declines
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 6 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
69%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
64%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (PHR: $13.13 vs. VEEV: $305.55)
Brand notoriety: PHR and VEEV are both not notable
Both companies represent the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: PHR: 76% vs. VEEV: 68%
Market capitalization -- PHR: $783.34M vs. VEEV: $49.18B
PHR [@Services to the Health Industry] is valued at $783.34M. VEEV’s [@Services to the Health Industry] market capitalization is $49.18B. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $708 to $49.18B. The average market capitalization across the [@Services to the Health Industry] industry is $3.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHR’s FA Score shows that 0 FA rating(s) are green while VEEV’s FA Score has 0 green FA rating(s).

  • PHR’s FA Score: 0 green, 5 red.
  • VEEV’s FA Score: 0 green, 5 red.
According to our system of comparison, VEEV is a better buy in the long-term than PHR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHR’s TA Score shows that 6 TA indicator(s) are bullish while VEEV’s TA Score has 4 bullish TA indicator(s).

  • PHR’s TA Score: 6 bullish, 4 bearish.
  • VEEV’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PHR is a better buy in the short-term than VEEV.

Price Growth

PHR (@Services to the Health Industry) experienced а +7.36% price change this week, while VEEV (@Services to the Health Industry) price change was +0.77% for the same time period.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was +0.21%. For the same industry, the average monthly price growth was +2.13%, and the average quarterly price growth was +27.96%.

Reported Earning Dates

PHR is expected to report earnings on Dec 02, 2026.

VEEV is expected to report earnings on Nov 19, 2026.

Industries' Descriptions

@Services to the Health Industry (+0.21% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

View a ticker or compare two or three
Interact to see
Advertisement

PHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHR has been loosely correlated with COIN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PHR jumps, then COIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHR
1D Price
Change %
PHR100%
+1.78%
COIN - PHR
57%
Loosely correlated
-2.92%
CLSK - PHR
55%
Loosely correlated
-4.92%
QTWO - PHR
49%
Loosely correlated
+1.47%
QLYS - PHR
49%
Loosely correlated
-13.51%
RIOT - PHR
49%
Loosely correlated
+2.38%
More

VEEV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VEEV has been loosely correlated with CLSK. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if VEEV jumps, then CLSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VEEV
1D Price
Change %
VEEV100%
-0.28%
CLSK - VEEV
55%
Loosely correlated
-4.92%
COIN - VEEV
54%
Loosely correlated
-2.92%
RIOT - VEEV
50%
Loosely correlated
+2.38%
WAY - VEEV
49%
Loosely correlated
+0.41%
PHR - VEEV
46%
Loosely correlated
+1.78%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSNC78.820.93
+1.19%
SS&C Technologies Holdings
TKLF1.45N/A
N/A
Tokyo Lifestyle Co Ltd
SLRC11.79-0.05
-0.42%
SLR Investment Corp
KBH50.47-1.54
-2.96%
KB Home
NERV2.49-0.14
-5.32%
Minerva Neurosciences